门诊手术中心初次全关节置换术的使用与报销:Medicare A 部分和 B 部分数据库分析
本研究分析2019至2022年Medicare A、B部分索赔数据,比较门诊手术中心(ASC)与住院及医院门诊环境中初次全关节置换术(TJA)的使用和报销趋势。结果显示ASC的TJA量大幅增加,每次手术报销最低,年节省费用显著,但经通胀调整后ASC报销下降,作者认为需持续监测报销政策。
要点
- 2019至2022年ASC的TJA量增加327.1%,其中TKA在2020至2022年增加193.8%,THA在2021至2022年增加61.1%。
- 2022年ASC占全部TJA的8.6%,每次手术报销最低(TKA 8,472.3美元;THA 8,578.7美元)。
- ASC的TJA平均报销名义上升3.9%,但经通胀调整下降8.1%,作者认为需持续监测报销政策。
核心结论
- 研究强调ASC的TJA量显著增加,其费用显著低于医院门诊或住院TJA,作者认为ASC正日益被接受为传统医院环境的可行且具成本效益的替代方案。
- 作者指出,随着ASC报销价值下降,需持续监测报销政策以确保ASC TJA的可持续性。
研究设计与样本
- 研究分析2019至2022年Medicare A部分和B部分索赔数据,比较ASC、医院门诊和住院环境的初次全膝关节置换术(TKA)和全髋关节置换术(THA)的计费与报销。
- 货币值使用消费者价格指数调整为2022年美元。
主要发现
- 2019至2022年共1,665,237例初次TJA索赔计费(TKA 1,079,846例;THA 585,391例),总使用量增加6.1%。
- ASC的TJA量增加327.1%,其中TKA在2020至2022年增加193.8%,THA在2021至2022年增加61.1%。
- 同期ASC的TJA平均报销上升3.9%(TKA 3.4%;THA 1.3%),但经通胀调整后下降8.1%(TKA -8.4%;THA -6.2%)。
- 到2022年,ASC占全部TJA的8.6%,每次手术报销最低(TKA 8,472.3美元;THA 8,578.7美元)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent changes in Medicare reimbursement policies have facilitated the shift of primary total joint arthroplasty (TJA) volume to ambulatory surgical centers (ASC). The ASCs potentially provide a more cost-effective alternative to a hospital-setting TJA. This study investigated Medicare primary TJA utilization and reimbursement trends at ASCs compared to inpatient and outpatient settings between 2019 and 2022. METHODS: Medicare Parts A and B claims data from the Centers for Medicare & Medicaid Services databases were analyzed. Primary total knee arthroplasty (TKA) and total hip arthroplasty (THA) procedures were identified based on respective settings and years. Billing data for ASCs, hospital outpatient departments, and inpatient TJA were compared. Monetary values were adjusted to 2022 dollars using the Consumer Price Index. RESULTS: From 2019 to 2022, 1,665,237 primary TJA claims were billed (TKA 1,079,846 claims; THA 585,391 claims), with a 6.1% increase in total utilization. The volume of ASC TJAs increased by 327.1% (TKA 193.8% from 2020 to 2022; THA 61.1% from 2021 to 2022). In the same period, average reimbursement for ASC TJAs rose by 3.9% (TKA 3.4%; THA 1.3%) but showed an 8.1% decline after adjusting for inflation (TKA -8.4%; THA -6.2%). By 2022, ASCs accounted for 8.6% of the total TJAs with the lowest reimbursement per procedure (TKA $8,472.3; THA $8,578.7). This shift to ASCs corresponded with $235 million saved compared to inpatient settings and $137 million saved compared to hospital outpatient departments per year. CONCLUSIONS: Our study highlights a marked increase in TJA volume at ASCs, with the procedure costing significantly less than HODP or inpatient TJAs. The findings underscore the growing acceptance of these centers as viable, cost-effective alternatives to traditional hospital settings. However, with the declining value of ASC reimbursements, continued monitoring of reimbursement policy is necessary to ensure the sustainability of ASC TJAs.
引用
- Seo HH, Shimizu MR, Buddhiraju A, et al. Utilization and Reimbursements of Primary Total Joint Arthroplasty in Ambulatory Surgical Centers: Analysis of Medicare Part A and B Databases. J Arthroplasty. 2024. PMID: 39586409. doi:10.1016/j.arth.2024.11.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。